Guests will include Carl Elliott, M.D., Ph.D., who will discuss his recent investigation of for-profit clinical trials that was published in The New Yorker magazine in January. Nearly 70 percent of Phase One trials are now conducted in for-profit clinics. This is a notable shift away from the old model, in which academic medical centers with strict ethical protocols managed the majority of Phase One trials. Dr. Elliott is professor in the Center for Bioethics at the University of Minnesota.
Also this week, two volunteers for Phase One trials who call themselves “guinea pigs” share their experiences of being in a trial.